Labroots Cancer Research

The Official @Labroots Cancer Research Page! We are here to discuss the most recent advances in cancer research and therapeutics. Please join our community! 🎗

[Labroots Cancer Research @Cancer_LR]

Scientists developed a novel way to treat cancer by engineering bacteria to deliver immune-stimulating viruses. Consequently, solid tumors were almost completely eliminated.

https://t.co/pmk8OlUIhU

[Labroots Cancer Research @Cancer_LR]

🧬 How are copy number variants shaping precision oncology? Join the June 4 webinar from @SOPHiAGENETICS: “Uncovering Copy Number Variants in Comprehensive Genomic Profiling”.

Register: https://t.co/zDepXEsJXY

#PrecisionMedicine #Genomics #Oncology #NGS

[Labroots Cancer Research @Cancer_LR]

Data presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting shows survival benefits for a combination approach involving a personalized cancer vaccine and immunotherapy.
https://t.co/4ZOMmz1fGN

[Labroots Cancer Research @Cancer_LR]

Cancer researchers rely on a spectrum of model systems, from classic murine syngeneic models to innovative organoid and organ-on-chip platforms. High-quality, in vivo–ready antibodies, validated, pure, and functional, are essential. https://t.co/4JngVPzlTq

[Labroots Cancer Research @Cancer_LR]

Overwhelmed by microscope options? Don’t guess - decide with confidence. "How to Choose the Right Benchtop Fluorescence Microscope for your Lab" highlights what really matters, helping you balance performance, usability, & budget for smarter lab decisions. https://t.co/qdDEOQzFMS

[Labroots Cancer Research @Cancer_LR]

🧬 How are copy number variants shaping precision oncology? Join the June 4 webinar from @SOPHiAGENETICS: “Uncovering Copy Number Variants in Comprehensive Genomic Profiling”.

Register: https://t.co/zDepXEsJXY

#PrecisionMedicine #Genomics #Oncology #NGS

[Labroots Cancer Research @Cancer_LR]

A new analysis looks at how prostate cancer mortality would change if indolent disease was relabeled as a precancerous condition.
https://t.co/pP1UyaRTHf

[Labroots Cancer Research @Cancer_LR]

From automated cell isolation & gene editing to cell expansion, formulation, fill-finish, & cryopreservation, the updated Cell Therapy Handbook explores key considerations of modern CAR-T manufacturing workflows for today’s biopharma & process dev teams. https://t.co/PjXd6C2Ysc

[Labroots Cancer Research @Cancer_LR]

Accelerate drug discovery screening with a smarter imaging workflow. Learn how fluorescent activity assays + selective “hit pick” imaging can reduce unnecessary imaging and deliver high-content insights for lead identification.

Download the app note: https://t.co/g1AzJoQaUi

[Labroots Cancer Research @Cancer_LR]

From Innovation to Clinical Practice: The Value of Whole Genome Sequencing in Pediatric Oncology 🧬 Join Dr. Lu Wang on June 10 to explore WGS, AI-driven MRD detection & clinical implementation. CE credits available. Register today! https://t.co/t74arzD1OM

[Labroots Cancer Research @Cancer_LR]

Researchers discover a "switch" in immune cells that improves cell activation. This new finding has the potential to enhance current immunotherapy for a wide range of diseases.

https://t.co/3VhCDQxwLb

[Labroots Cancer Research @Cancer_LR]

Bridging the gap between discovery and clinical translation in spatial proteomics is getting more affordable. Join experts on June 3, to see how a new imaging workflow cuts costs by 75%. @invitrogen Register now: https://t.co/vC4eJbrPvu

[Labroots Cancer Research @Cancer_LR]

iPSC experiments often fail quietly—loss of pluripotency, hidden stress, growing variability. Learn how continuous monitoring helps researchers catch problems earlier & protect cell quality across culture, discovery, & disease modeling workflows. https://t.co/CT4D0UFVv3

[Labroots Cancer Research @Cancer_LR]

Download our three-poster bundle featuring early developability assessment, HTP SPR analysis, and MOA-driven assays for diverse modalities like mAbs, bispecifics/TCEs, and ADCs. https://t.co/Y0VBM19fJt

[Labroots Cancer Research @Cancer_LR]

Today we recognize the brave veterans who died while serving their country.
https://t.co/aeXW0Vi0C0

[Labroots Cancer Research @Cancer_LR]

Interim clinical trial data shows that an antibody-drug conjugate has benefits for endometrial cancer patients.
https://t.co/1nU0txQDRQ

[Labroots Cancer Research @Cancer_LR]

Researchers have discovered a new way to expand immune cells in solid tumors. This novel approach improves our understanding of tumor biology and will better inform the development of cancer treatments.

https://t.co/M7y0nlso8s

[Labroots Cancer Research @Cancer_LR]

Scientists developed an effective CAR T cell immunotherapy in preclinical models of brain cancer. This novel treatment strategy has the potential to improve standard-of-care therapy for patients with brain cancer.

https://t.co/TmGAlKhiqv

[Labroots Cancer Research @Cancer_LR]

A JAMA Oncology study shows that early-stage lung cancer diagnoses in the U.S. rose from 17.6% in 2003 to 30.1% in 2022, following updated screening guidelines for high-risk adults. https://t.co/rYGXJdi6yD

[Labroots Cancer Research @Cancer_LR]

A study in Nature shows that grouping gut microbes by evolutionary adaptation, rather than species, reveals dynamic, globally shared bacterial strains uniquely linked to diseases like diabetes and colorectal cancer. https://t.co/yKR2QGAOrx